A Novel Il-23p19/Ebi3 (Il-39) Cytokine Mediates Inflammation in Lupus-Like Mice

Xiaoqian Wang,Yinxiang Wei,He Xiao,Xiaoling Liu,Yu Zhang,Gencheng Han,Guojiang Chen,Chunmei Hou,Ning Ma,Beifen Shen,Yan Li,Charles E. Egwuagu,Renxi Wang
DOI: https://doi.org/10.1002/eji.201546095
2016-01-01
European Journal of Immunology
Abstract:Interleukin-12 family cytokines have emerged as critical regulators of immunity with some members (IL-12, IL-23) associated with disease pathogenesis while others (IL-27, IL-35) mitigate autoimmune diseases. Each IL-12 family member is comprised of an alpha and a beta chain, and chain-sharing is a key feature. Although four bona fide members have thus far been described, promiscuous chain-pairing between alpha (IL-23p19, IL-27p28, IL-12/IL-35p35) and beta (IL-12/IL-23p40, IL-27/IL-35Ebi3) subunits, predicts six possible heterodimeric IL-12 family cytokines. Here, we describe a new IL-12member composed of IL-23p19 and Ebi3 heterodimer (IL-39) that is secreted by LPS-stimulated B cells and GL7(+) activated B cells of lupus-like mice. We further show that IL-39 mediates inflammatory responses through activation of STAT1/STAT3 in lupus-like mice. Taken together, our results show that IL-39 might contribute to immunopathogenic mechanisms of systemic lupus erythematosus, and could be used as a possible target for its treatment.
What problem does this paper attempt to address?